CSL (MEX:CSL N) 9-Day RSI: N/A (As of Jul. 03, 2026)


MEX:CSL N CSL Ltd MEX:CSL N
79 GF Score
Price MXN2,081.30
GF Value MXN5,073.25
! 7 Warning Signs
View Full Analysis

What is CSL 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-03), CSL's 9-Day RSI is N/A.

The industry rank for CSL's 9-Day RSI or its related term are showing as below:

MEX:CSL N's 9-Day RSI is not ranked *
in the Biotechnology industry.
Industry Median: 51.47
* Ranked among companies with meaningful 9-Day RSI only.

CSL  (MEX:CSL N) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

CSL 9-Day RSI Related Terms

MEX:CSL N vs VRTX, REGN, ALNY: 9-Day RSI Comparison

For the Biotechnology subindustry, CSL's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSL 9-Day RSI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CSL's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where CSL's 9-Day RSI falls into.


MEX:CSL N
79GF Score
CSL Ltd MEX:CSL N
9-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSL  (MEX:CSL N) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is CSL (MEX:CSL N) Overvalued in 2026?

Based on GuruFocus' analysis, CSL stock appears to be undervalued. The current stock price of MXN2,081.30 is trading 59% below its estimated GF Value™ of MXN5,073.25.

Key valuation signals for MEX:CSL N:

  • 9-Day RSI: N/A
  • GF Value™: MXN5,073.25 vs. price of MXN2,081.30 (59% below fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the MEX:CSL N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSL Business Description

Address 655 Elizabeth Street, Melbourne, VIC, AUS, 3000
CSL is one of the largest global biotech companies and has three main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders, and neurological indications. CSL Seqirus is the world's second-largest influenza vaccination business and was acquired in fiscal 2016. CSL Vifor is an iron deficiency and nephrology business and was acquired in fiscal 2023. CSL has a strong R&D track record, and the product portfolio and pipeline include nonplasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.
79GF Score

Get the complete analysis for MEX:CSL N

9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,081.30
Price
MXN5,073.25
GF Value